TALPHERA, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
TALPHERA, INC. (TLPH) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $243.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-12
- TALPHERA, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $243.00K, a 46.39% increase year-over-year.
- TALPHERA, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $214.00K, a 9.18% increase year-over-year.
- TALPHERA, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $152.00K, a 35.04% decline year-over-year.
- TALPHERA, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $166.00K, a 25.56% decline year-over-year.
- TALPHERA, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $699.00K, a 29.32% decline from fiscal 2024.
- TALPHERA, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $989.00K, a 42.80% decline from fiscal 2023.
- TALPHERA, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $1.73M, a 40.15% decline from fiscal 2022.
- TALPHERA, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $2.89M.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 2 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $243.00K 10-Q · filed 2026-08-12 | $457.00K derived: sum of 2 quarters · filed 2026-08-12 | |||
| 2026-03-31 | $214.00K 10-Q · filed 2026-08-12 | ||||
| 2025-12-31 | $699.00K 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | $152.00K 10-Q · filed 2025-11-12 | $318.00K derived: sum of 2 quarters · filed 2026-08-12 | $514.00K derived: sum of 3 quarters · filed 2026-08-12 | ||
| 2025-06-30 | $166.00K 10-Q · filed 2026-08-12 | $362.00K derived: sum of 2 quarters · filed 2026-08-12 | |||
| 2025-03-31 | $196.00K 10-Q · filed 2026-08-12 | ||||
| 2024-12-31 | $989.00K 10-K · filed 2026-03-23 | ||||
| 2024-09-30 | $234.00K 10-Q · filed 2025-11-12 | $457.00K derived: sum of 2 quarters · filed 2025-11-12 | $759.00K derived: sum of 3 quarters · filed 2025-11-12 | ||
| 2024-06-30 | $223.00K 10-Q · filed 2025-11-12 | $525.00K derived: sum of 2 quarters · filed 2025-11-12 | |||
| 2024-03-31 | $302.00K 10-Q · filed 2025-11-12 | ||||
| 2023-12-31 | $1.73M 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | $378.00K 10-Q · filed 2024-11-13 | $849.00K derived: sum of 2 quarters · filed 2024-11-13 | $1.42M derived: sum of 3 quarters · filed 2024-11-13 | ||
| 2023-06-30 | $471.00K 10-Q · filed 2024-11-13 | $1.04M derived: sum of 2 quarters · filed 2024-11-13 | |||
| 2023-03-31 | $569.00K 10-Q · filed 2024-11-13 | ||||
| 2022-12-31 | $2.89M 10-K · filed 2024-03-06 | ||||
| 2022-09-30 | $701.00K 10-Q · filed 2023-11-14 | $1.45M derived: sum of 2 quarters · filed 2023-11-14 | $2.24M derived: sum of 3 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $753.00K 10-Q · filed 2023-11-14 | $1.54M derived: sum of 2 quarters · filed 2023-11-14 | |||
| 2022-03-31 | $783.00K 10-Q · filed 2023-11-14 | ||||
| 2021-12-31 | $4.61M 8-K · filed 2023-08-01 | ||||
| 2021-09-30 | $1.22M 10-Q · filed 2022-11-14 | $2.39M derived: sum of 2 quarters · filed 2022-11-14 | $3.48M derived: sum of 3 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $1.17M 10-Q · filed 2022-11-14 | $2.26M derived: sum of 2 quarters · filed 2022-11-14 | |||
| 2021-03-31 | $1.09M 10-Q · filed 2022-11-14 | ||||
| 2020-12-31 | $4.42M 10-K · filed 2022-03-10 | ||||
| 2020-09-30 | $1.10M 10-Q · filed 2021-11-15 | $2.19M derived: sum of 2 quarters · filed 2021-11-15 | $3.34M derived: sum of 3 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $1.09M 10-Q · filed 2021-11-15 | $2.24M derived: sum of 2 quarters · filed 2021-11-15 | |||
| 2020-03-31 | $1.15M 10-Q · filed 2021-11-15 | ||||
| 2020-03-01 | $1.15M 10-Q · filed 2021-05-17 | ||||
| 2019-12-31 | $5.06M 10-K · filed 2021-03-15 | ||||
| 2019-09-30 | $1.33M 10-Q · filed 2020-11-05 | $2.67M derived: sum of 2 quarters · filed 2020-11-05 | $3.78M derived: sum of 3 quarters · filed 2020-11-05 | ||
| 2019-06-30 | $1.35M 10-Q · filed 2020-11-05 | $2.45M derived: sum of 2 quarters · filed 2020-11-05 | |||
| 2019-03-31 | $1.11M 10-Q · filed 2020-11-05 | ||||
| 2018-12-31 | $5.17M 10-K · filed 2021-03-15 | ||||
| 2018-09-30 | $1.81M 10-Q · filed 2019-11-07 | $2.86M derived: sum of 2 quarters · filed 2019-11-07 | $3.94M derived: sum of 3 quarters · filed 2019-11-07 | ||
| 2018-06-30 | $1.05M 10-Q · filed 2019-11-07 | $2.13M derived: sum of 2 quarters · filed 2019-11-07 | |||
| 2018-03-31 | $1.08M 10-Q · filed 2019-11-07 | ||||
| 2017-12-31 | $4.29M 10-K · filed 2020-03-16 | ||||
| 2016-12-31 | $4.48M 10-K · filed 2019-03-07 | ||||
| 2015-12-31 | $5.01M 10-K · filed 2018-03-09 | ||||
| 2014-12-31 | $4.44M 10-K · filed 2017-03-03 | ||||
| 2013-12-31 | $3.48M 10-K · filed 2016-03-07 | ||||
| 2012-12-31 | $2.15M 10-K · filed 2015-03-13 | ||||
| 2011-12-31 | $1.83M 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |